Back to Journal

SM Analytical and Bioanalytical Techniques

Formulations Prepared with Bioadhesive Polymers for Application in Vaginal Mucosa

[ ISSN : 2573-3729 ]

Abstract CITATION Introduction Conclusion Future Perspectives Financial and Competing Interests Disclosure References
Details

Received: 02-Nov-2017

Accepted: 03-Nov-2017

Published: 06-Nov-2017

Maíra N Pereira and Guilherme M Gelfuso* 

Departamento de Farmácia, University of Brasília (UnB), Brazil

Corresponding Author:

Guilherme M Gelfuso, Laboratory of Food, Drug and Cosmetics (LTMAC), School of Health Sciences, University of Brasília (UnB), Brasília, DF, Brazil, Tel: 70910-900; Email: gmgelfuso@yahoo.com

Keywords

Vagina; Topical delivery; Mucoadhesive polymer

Abstract

T he vaginal lumen is affected by several pathologies - most of them are vaginitis caused by bacteria, fungi, protozoa or viruses. A considerable number of antimicrobial, antiviral, antifungal and antiprotozoal drugs have been therefore traditionally administered into this site, as well as spermicidal agents, prostaglandins and steroids.

CITATION

Pereira MN and Gelfuso GM. Formulations Prepared with Bioadhesive Polymers for Application in Vaginal Mucosa. SM Anal Bioanal Technique. 2017; 2(2): 1012s1.

Introduction

The vaginal lumen is affected by several pathologies - most of them are vaginitis caused by bacteria, fungi, protozoa or viruses. A considerable number of antimicrobial, antiviral, antifungal and antiprotozoal drugs have been therefore traditionally administered into this site, as well as spermicidal agents, prostaglandins and steroids [1,2]. It is obvious that topical vaginal application of drugs is advantageous over oral or other systemical route ofadministration, once important adverse effects such as nausea, vomiting, abdominal painor menstrual disorders are avoided, even as numerous interactions between drugs could be eliminated [3,4]. Topical absorption, however, is hampered by the physiological removal mechanisms present in the vaginal lumen, which are responsible for the short ER retention time of conventional formulations at the site of action, causing the irregular distribution of the drug through the mucosa. In addition, if one consider vagina is an intimate place, the need for continuous application of conventional topical formulations in this site throughout theday causes discomfort to the patient and reduces therapeutic adherence [5–7].

Since 1980, bioadhesive formulations have been available in market and have proven to be specially important for application in topical drug delivery routes. Previous applications of bioadhesive delivery systems mainly involved the oral cavity and the gastrointestinal tract, but currently, these systems have been developed to target a wider variety of mucosal surfaces including the vaginal mucosa. For drug delivery purposes, theterm “bioadhesion” implies binding of a drug delivery system to a specific biological site. If the adhesiveis for a mucosa, the phenomenon is referred to as mucoadhesion [8,9].

The mucoadhesion mechanisms involve, first, a contact stage, in which hydration, wetting and scattering are the most important steps, and subsequently a consolidation stage, which involves the strengthening of the polymer-mucin-type junction due to the interpenetration of the chains polymerization in the mucus layer and the occurrence of polymer-mucin binding formation (mainly Van der Waals forces, hydrogen bonds or electrostatic interactions) [5,10].

Mucoadhesion is generally obtained using both natural bioadhesive (such as tragacanth, sodium alginate, Karaya gum, Guar gum, Xanthan gum, soluble starch,gelatin, pectin and chitosan) and synthetic polymers (cellulose derivatives, polyacrylic acid polymers, polyhydroxy ethyl methyl acrylate, polyethylene oxide, poly vinyl pyrrolidone, poly vinyl alcohol and, more recently, thyolated polymers) [11,12].

Among this range of options, polyacrylic acid and hydroxypropyl methyl cellulose are the ones with the highest mucoadhesive strength. In general, traditional vaginal dosage forms include solutions, suspensions, gels, suppositories, creams, foams and tablets [13,14].

Such polymers may further be divided into anionic, cationic or nonionic. Cationic polymers, such as chitosan, form bonds with negatively charged mucinchains and anionic polymers have muco adhesive properties due to hydrogen bonding to the mucosal layer [15].

Anionic polymers are singled out as preferred over cationic polymers for adhesion and toxicity potential. In addition, carboxylated anionic polymers appeared to be favored compared to sulfated [16]. I

n order for the polymers to succeed in their bioadhesive function on the mucosal surfaces they must have a molecular weight of 100,000 Da or more, excellent polymer concentration, adequate flexibility to control the extent of interpenetration between the polymers and the mucous membranes, surface tensions capable of spreading the bioadhesive polymer on the epithelial surface of the mucosal layer, strong hydrogen bonding groups (-OH, - COOH) and strong anionic charges [4,9]. The duration of the contact, the diffusion coefficient and the solubility of the Se materials at the mucus interface determine their level of muco adhesion [17].

In recent years, a large quantity of studies have focused on the development of systems with bioadhesive properties. Although most bioadhesive vaginal formulations are semi-solid (especially gels), other dosage forms such as tablets and films have also be enproduced [18,19]. An ideal polymer for a mucoadhesive vaginal delivery system should be non-toxic and non-irritating to the mucosa, adhere rapidly to the tissue, allow easy incorporation of the drug, not obstruct drug release, to possess low cost and have good comfort and convenience [20,21].

One imporntant study developed an intra vaginal bioadhesive table to polystyrene sulfonate loaded with azidothymidine. In general, there sults suggested the system maybe sufficiently bioadhesive with desirable physicochemical and physicomechanical stability for use as a prolonged intra vaginal drug delivery [22]. Another recent study developed a bioadhesive vaginal microbial gel using the two polymers Pluronic® F-127 and Noveon® AA-1 for the administration of antiHIV agents, demonstrating ideal bioadhesion and drug retention in vaginal tissue [23]. More recently, liposomes coated with natural and synthetic bioadhesive polymers (chitosan and Carbopol, respectively) containing curcumin were evaluated by an in vitromodelof vaginal mucus. For control and comparison purposes, liposomes withou tthe coatings were also developed and there sults showed that the bioadhesive polymers allowed significantly greater (p < 0.05) curcumin permeability through the mucosa in comparison to the control [24].

It is evident that in the development of a bioadhesive delivery system, the evaluation of adhesive properties of the formulation is essential. In this way, several in vitro methods have been developed for this purpose, such as: tensile test, shear strength and peel strength [12,25]. Additionally, several physical techniques, such as rheological, optical and spectroscopichave also been applied to evaluate the nature and intensity of mucoadhesive interactions [15]. These methods, however, do not consider biological and anatomical properties of vaginal that are crucial in the formulation performance. In such context, our research group has developed a novel and simplex vivo protocol consisting of a vertical permeation system that uses porcine vagina freshly removed from the animal. This systemhas proved to pose physiological conditions similar with reality in evaluating the vaginal absorption of new mucoadhesive systems in comparison with non adhesive formulations [26].

Conclusion

The adhesion property of bioadhesivepolymeric systems offers a potential to prolong the residence time of the dosage form at the vaginal lumen.Consequently, they lead to an increase in drug concentration at the site of action, thus reducing dosing frequency. In addition, patient compliance is improved as well as a better chemical and physical stability of the systems [13,25].

Future Perspectives

The development of new delivery systems with mucoadhesive properties is one of the most challenging research topics in the field of topical drug delivery systems. The use of mucoadhesive polymers to increase contact time for a wide variety of drugs in the vaginal route showed dramatic improvement in therapies and greater patient comfort. Many potential mucoadhesive systems must be investigated so that they can find their way into the market in the near future.

Financial and Competing Interests Disclosure

The authors acknowledge the financial support of Coordenação De Aperfeiçoamento De Pessoal De Nível Superior (CAPES), Brazil; Conselho Nacional De Desenvolvimento Científico E Tecnológico (CNPq), Brazil, and Fundação De Apoio À Pesquisa Do Distrito Federal (FAPDF), Brazil. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.

References

1. Da Silva PB, Ramos MADS, Bonifácio BV, Negri KMS, Sato MR, Bauab TM, et al. Nanotechnological strategies for vaginal administration of drugs - A review. J Biomed Nanotechnol. 2014; 10: 2218-2243.

2. Bassi P, Kaur G. Innovations in bioadhesive vaginal drug delivery system. Expert Opin Ther Pat. 2012; 22: 1019-1032.

3. Chuah LH, Roberts CJ, Billa N, Abdullah S, Rosli R. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Colloids Surfaces B Biointerfaces. 2014; 116: 228-236.

4. Mythri G, Kavitha K, Kumar MR, Jagadeesh Singh SD. Novel mucoadhesive polymers- A review. J Appl Pharm Sci. 2011; 1: 37-42.

5. Caramella CM, Rossi S, Ferrari F, Bonferoni MC, Sandri G. Mucoadhesive and thermogelling systems for vaginal drug delivery. Adv Drug Deliv Rev. 2015; 92: 39-52.

6. Hiorth M, Nilsen S, Tho I. Bioadhesive mini-tablets for vaginal drug delivery. Pharmaceutics. 2014; 6: 494-511.

7.Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. Polymers for mucoadhesive drug delivery system: A current status. Drug Dev Ind Pharm. 2008; 34: 1246-1266.

8. Boddupalli B, Mohammed Z, Nath R, Banji D. Mucoadhesive drug delivery system: An overview. J Adv Pharm Technol Res. 2010; 1: 381.

9. Saraswathi B, Balaji A, Umashankar MS. Polymers in mucoadhesive drug delivery system - Latest updates. Int J Pharm Pharm Sci. 2013; 5: 423-430.

10. Pathan SA, Iqbal Z, Sahani JK, Talegaonkar S, Khar RK, Ahmad FJ. Buccoadhensive drug delivery systems - Extensive review on recent patents. Recent Patents Drug Deliv Formul. 2008; 2: 177-188.

11. Andrade AO, Parente ME, Ares G. Screening of mucoadhesive vaginal gel formulations. Brazilian J Pharm Sci. 2014; 50: 931-942.

12. Acartürk F. Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul. 2009; 3: 193-205.

13. Yadav VK, Gupta AB, Kumar R, Yadav JS, Kumar B. Mucoadhesive Polymers: Means of Improving the Mucoadhesive Properties of Drug Delivery System. J Chem Pharm Res. 2010; 2: 482-488.

14. Krishna Moorthy B, Muthukumaran M. Recent Advances in Mucoadhesive/ Bioadhesive Drug Delivery System: a Review. Int J Pharm Med Bio Sc Phanindra B al. 2013; 2: 68-84.

15. Woertz C, Preis M, Breitkreutz J, Kleinebudde P. Assessment of test methods evaluating mucoadhesive polymers and dosage forms: An overview. Eur J Pharm Biopharm. 2013; 85: 843-853.

16. Park KK, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery: Method to study bioadhesion. Int J Pharm. 1984; 19: 107-127.

17. Wong TW, Dhanawat M, Rathbone MJ. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development. Expert Opin Drug Deliv. 2014; 11: 1-16.

18. Mirza MA, Panda AK, Asif S, Verma D, Talegaonkar S, Manzoor N, et al. A vaginal drug delivery model. Drug Deliv. 2016; 7544:1-12.

19. Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev. 2005; 57: 1692-1712.

20. De Araújo Pereira RR, Bruschi ML. Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 2012; 38: 643-652.

21. Laffleur F, Bernkop-Schnürch A. Strategies for improving mucosal drugdelivery. Nanomedicine (Lond). 2013; 8: 2061-2075.

22. Ndesendo V, Pillay V, Choonara Y, Toit L, Buchmann E, Meyer L, et al. Investigation of the Physicochemical and Physicomechanical Properties of a Novel Intravaginal Bioadhesive Polymeric Device in the Pig Model. AAPS PharmSciTech. 2010; 11: 793-808.

23. Podaralla S, Alt C, Shankar GN. Formulation Development and Evaluation of Innovative Two-Polymer (SR-2P) Bioadhesive Vaginal Gel. AAPS PharmSciTech. 2014; 15: 928-938.

24. Berginc K, Suljaković S, Škalko-Basnet N, Kristl A. Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin. Eur J Pharm Biopharm. 2014; 87: 40-46.

25. Shaikh R, Singh TRR, Garland MJ, Woolfson AD, Donnelly RF. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011; 3: 89.

26. Pereira MN, Reis TA, Matos BN, Cunha-Filho M, Gratieri T, Gelfuso GM. Novel ex vivo protocol using porcine vagina to assess drug permeation from mucoadhesive and colloidal pharmaceutical systems. Colloids Surfaces B Biointerfaces. 2017; 158: 222-228.

Other Articles

Article Image 1

Drug Optimization: Fighting Research to Achieve the Greatest Use of Darunavir

A design has been development that provides higher activity to darunavir, an antiretroviral drug, aiming a lower dose in the battle against HIV in children and adults. Globally this research paves the way to get a new darunavir: β-cyclodextrin complex driving future perspectives to new anti HIV drugs for clinical applications. β-cyclodextrins not only promote the solubility of darunavir, but can drive to development of new complexes able to combat HIV in lower doses and, therefore lower toxic effects. Analysis methods by chromatography, also, were developed to evaluated the quality of the complexed darunavir. All this effort to contemplate the patients of all ages and provide quality medicines as well as a better quality of life.

Ana Carolina Kogawa¹ and Hérida Regina Nunes Salgado¹*


Article Image 1

Enhancing Throughput of Glutathione Adduct Formation Studies and Structural Identification Using a Software-Assisted Workflow Based on High-Resolution Mass Spectrometry (HRMS) Data

The bioactivation of drugs to Reactive Metabolites (RM) has been related to drug-induced liver injury and hypersensitivity reactions in patients. Therefore, many pharmaceutical companies are investigating the potential to form reactive metabolites in vitro as an integral part of the optimization of drug candidates. A computer assisted workflow to efficiently analyze larger numbers of compounds for the formation of glutathione trappable RM is presented here. A set of 95 compounds with known bioactivation potential was selected for this study. Incubations with human liver microsomes were prepared with GSH. The acquisition of MS/MS spectra was triggered by ion intensity. MS with singly and doubly charged ions were used for peak detection and MS/MS spectra were used for structural elucidation. A confidence classification system for the GSH peak detection (high, medium, low) was developed based on the detection of characteristic fragment ions or neutral losses and applied to remove potential false positive results. A comparative analysis of the HRMS results with literature data was carried out. The most frequently observed Neutral Loss (NL) found in singly charged GSH adducts (drug-glutathione conjugates) were, the Neutral Loss (NL, 129 Da) and Fragment Ion (FI, m/z 308) and in the doubly charged ones the Fragment Ion (FI, m/z 130). These NL and FI were used to identify GSH-related drug metabolites. MS/MS spectra were inspected to aid structural elucidations: 17% of drug substrates and 29 % of GSH adduct metabolites were identified with only doubly charged ions, stressing the importance of considering this charge state in the identification workflow. A total of 41 compounds that form GSH adducts were retrieved from literature (HRMS, identified 28 compounds (68%) in high confidence, and the same result was obtained using precursor ion scan). By the confidence analysis of GSH peaks, the quality of the each GSH adduct was determined.

Esra Nurten Cece-Esencan¹, Fabien Fontaine², Guillem Plasencia²,³, Marieke Teppner³, Andreas Brink³, Axel Pähler³, and Ismael Zamora⁴*


Article Image 1

Evaluation of Solid Phase Extraction NH2 for Determination of Enniatins (A, A1, B, B1) and Beauvericin in Cereals by UPLC-MS/MS

We report herein, for the first time, the application of NH2 solid-phase extraction NH2 (NH2-SPE) cartridge for cleanup of enniatins (ENA, ENA1 , ENB, ENB1 ) and Beauvericin (BEA) in cereals. Samples were sequentially extracted with a solution containing 80% acetonitrile and 0.1% formic acid and the extracts were cleaned up with NH2-SPE cartridges before being analyzed by Ultra-High Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS/MS). A CORTECS C18 column was used for separation of enniatins and beauvericin. Mass spectrometric analysis was conducted at the Positive Electrospray Ionization (ESI+) Mode with Multi Reactions Monitoring (MRM). Very good linear relationships between spiked levels of ENA, ENA1, ENB, ENB1, BEA in cereals and mass spectra were observed with regression coefficients of 0.995 to 0.999 and Detection Limits (LOD) range of 0.01 to 0.1 µg kg-1. Clean up with NH2-SPE cartridge gave more satisfactory recoveries ranging from 80.9% to 109.8% than with QuEChERS method that gave recoveries between 63.5% to 96.6%. Application of the NH2-SPE cartridge for the determination of enniatins and beauvericin showed detection levels ranging from 0.01 µg kg-1 to 127.87 µg kg-1 in corn and 0.01 µg kg-1 to 116.59 µg kg-1 for wheat.

Juan Sun, Weixi Li, Yan Zhang, Huijie Zhang, Li Wu, Xuexu Hu and Bujun Wang*


Article Image 1

Electroanalysis: Towards a

Recent trends in the sensor community, indicates that one of the major challenges and opportunities of the field relies on developing smart sensor platforms, which are cheap, efficient, easy-to-use, and capable of minimizing tasks at the end user stage, in comparison to traditionally used methods which require bulky instrumentations and qualified personnel.

Stefano Cinti*


Article Image 1

Chemistry in Sustainability and Chemistry of Sustainability: Waste of use of Fishing Industry for Removal of Waste Textile Industry

One of the negative consequences related to socioeconomic development in recent centuries has been the rise of environmental contamination. In light of this, human has sought to implement actions in all spheres (social, economic and cultural) aiming to minimize the impact on the environment. Concern about the pollution of bodies of water and industrial wastewater treatment is the biggest worry in this regard. Among various treatment methods highlights the adsorption solid phase, by being very efficient and economically feasible. The use of chitosan as an adsorbent makes the process more ecologically interesting, once chitosan is also retrieved from waste. In this study we evaluate the adsorption process of the bromothymol blue dye by the chitosan. The parameters that influence the sorption process were studied (pH, ionic strength, adsorbent mass and dye initial concentration), and the process thermodynamics.

Francisco JE¹, Cajé JCM¹, Semaan FS¹, and Pacheco WF¹*


Article Image 1

Sorption Properties of Methyl Orange onto Chemically Modified Chitosan: Thermodynamics and Kinetics Studies

A new kind of sorbent with high adsorption capacity and stability was prepared using chitosan and epichlorohydrin through a cross-linking reaction and assessed by using methyl orange. The sorption capability was evaluated by means of kinetics and equilibrium studies. Relevant factors for such sorption process were also assessed. After optimization of the relevant sorption factors, the percentages for methyl orange removal by chitosan and by modified chitosan were 82%, and 67%, respectively. Although the cross-linked chitosan offered the lowest removal percentage, this sorbent presented other relevant advantages when compared to non-modified chitosan, such as higher chemical and thermal stabilities.

Juliana CM Caje, Paula Marcelle de Oliveira, Felipe S Semaan, Raphael C Cruz, Ricardo J. Cassella and Wagner F. Pacheco


Article Image 1

Quantitative Headspace Solid-Phase Microextraction Gas Chromatography Mass Spectrometry (HS-SPME-GC-MS/ MS) Method for the Determination of Tributyltin in Sediment: Validation according to EU Directive Requirement

The Directive 2013/39/EU has reviewed the list of priority substances under the European Water Framework Directive (WFD; Directive 2000/60/EC) and has strengthened the principle of flexibility for Member States in applying the Environmental Quality Standard (EQS) for alternative matrices. Coherently, it has established new EQS for biota and it has invited Member States to set EQS for more opportune matrices, able to advantage the monitoring strategy and offer the same level of protection, such as sediment. The present work developed a (HS)SPME-GC-MS/MS method for the analysis of Tributyltin (TBT) in sediment samples and, through an in depth validation process, it assessed the compliance with the technical specification required by the EU Directive 2009/90/EC for chemical status analysis under the scope of the WFD. The EQS established for TBT in sediment by the Italian Environmental Ministry was used as reference. The method fulfils the minimum performance criteria required by the EU Directive 2009/90/EC (Method Detection Limit (MDL) and Minimum Level Of Quantitation (ML), expressed as ng Sn g-1 d.w., were 0.2 and 0.5, respectively). More generally, the analytical figures of merit achieved, were satisfying for the target TBT concentration range (recovery: 90-111%, intermediate precision range: 6-12%).

Seta Noventa¹, Malgorzata Formalewicz¹, Jvan Barbaro², Claudia Gion¹, Federico Rampazzo¹, Massimo Gabellini³, Rossella Boscolo¹, and Daniela Berto¹*

 


Article Image 1

Method Development and Validation for the Determination of Pravastatin in Human Plasma by Lc-Ms/Ms

A simple, rapid, sensitive and selective liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and validated for the quantification of pravastatin in human plasma. Pravastatin-D3 was used as an internal standard. The analyte was extracted from human plasma samples by liquid-liquid extraction technique. Due to the presence of isobaric metabolites, 3α-iso-pravastatin and 6-epi-pravastatin, chromatographic conditions were optimized, with a C18 column by using a mixture of 0.1% acetic acid in water and acetonitrile/ methanol (43:57,v/v) as the mobile phase at a flow rate of 0.6 mL/min. The calibration curve obtained was linear (r2 ≥ 0.9900) over the concentration range of 0.500-500 ng/mL. Method validation was performed as per FDA guidelines and the results met the acceptance criteria. The method was suitable for supporting clinical studies.

Lian Chen, Paresh Joshi, Andrii Piatkivskyi, Kalem Aguilar, and Jenny Lin*


Article Image 1

Cramer Rao Lower Bound CRB Shape Detection Method

In this paper we investigate the problem of tracking a moving but non-vibrating cylindrical object and estimating its size and shape using an artificial lateral line system, an d determine the lower bound that the estimator can be reached. Based on a nonlinear analytical model for the moving object-induced flow field, a two-stage extended Kalman filter is proposed to estimate the location, velocity, size, and shapes of the object. Simulation results on tracking an ellipsoidal cross-section are presented to illustrate the approach.

Ahmad T Abdulsadda*


Article Image 1

Composition and Antioxidant Activity of Vitex agnus-castus L and Rosmarinus Officinalis L. Leaves Essential Oils Cultivated in Syria

Medicinal plants contain a wide variety of chemicals which have very important roles in numerous applications including medicinal and those related with industry. Essential oils represent valuable sources for natural antioxidants. The aim of our study was to evaluate the chemical composition and antioxidant activity of the essential oils extracted from leaves of Syrian Vitex agnus-castus L. and Rosmarinus officinalis L., where is both essential oils were extracted and analyzed by gas chromatography-mass spectrometry. The antioxidant activities of these essential oils were determined by three different test systems, scavenging effect on 2,2-diphenyl-1-picrylhydrazyl radical, total phenolic and flavonoids contents. The main constituents found in Vitex agnus-castus L. essential oil were 1,8-Cineole (19.34%) and Sabinene (12.50%), while the major constituents in Rosmarinus officinalis L. essential oil were 1,8-Cineole (28.03%) and α-Pinene (14.70%). The results showed that 2,2-diphenyl-1-picrylhydrazyl radical scavenging and total phenolic contents of Vitex agnus-castus L. essential oil were higher than Rosmarinus officinalis L. essential oil. Total flavonoids contents were not detected in both essential oils. The Vitex agnus-castus L. and Rosmarinus officinalis L. essential oils are sources of natural antioxidants. Therefore, further work is needed to identify the compound(s) responsible for the antioxidant activity of Vitex agnus-castus L. and Rosmarinus officinalis L. essential oils.

Faten Al Saka, Manal Daghestani, and Francois Karabet*